Advanced search
Publication Cover
Future Oncology Volume 8, 2012 - Issue 7
Submit an article Journal homepage
209
Views
0
CrossRef citations to date
0
Altmetric
Review

The Multifaceted Actions of PTHrP in Skeletal Metastasis

Fabiana N Soki1 Department of Periodontics & Oral Medicine, University of Michigan School of Dentistry, 1011 North University Avenue, Ann Arbor, MI, USAView further author information
,
Serk In Park1 Department of Periodontics & Oral Medicine, University of Michigan School of Dentistry, 1011 North University Avenue, Ann Arbor, MI, USAView further author information
&
Laurie K McCauley1 Department of Periodontics & Oral Medicine, University of Michigan School of Dentistry, 1011 North University Avenue, Ann Arbor, MI, USA;2 Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. [email protected]Correspondence[email protected]
View further author information
Pages 803-817 | Published online: 25 Jul 2012

References

  • Mundy GR . Metastasis to bone: causes, consequences and therapeutic opportunities.Nat. Rev. Cancer2(8), 584–593 (2002).
  • McCauley LK , MartinTJ. Twenty-five years of PTHrP progress from cancer hormone to multi-functional cytokine.J. Bone Miner. Res.27(6), 1231–1239 (2012).
  • Kramer B , TisdallFF. A simple technique for the determination of calcium and magnesium in small amounts of serum.J. Biol. Chem.47(3), 475–481 (1921).
  • Albright F . Case records of the Massachusetts General Hospital.N. Engl. J. Med.225, 789–791, Case 27461 (1941).
  • Clines GA , GuiseTA. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.Endocr. Relat. Cancer12(3), 549–583 (2005).
  • Manring MM , CalhounJH. Biographical sketch: Fuller Albright, MD 1900–1969.Clin. Orthop. Relat. Res.469(8), 2092–2095 (2011).
  • Suva LJ , WinslowGA, WettenhallREet al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237(4817), 893–896 (1987).
  • Strewler GJ , SternPH, JacobsJWet al. Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J. Clin. Invest. 80(6), 1803–1807 (1987).
  • Burtis WJ , WuT, BunchCet al. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J. Biol. Chem. 262(15), 7151–7156 (1987).
  • Stewart AF , BurtisWJ, WuT, GoumasD, BroadusAE. Two forms of parathyroid hormone-like adenylate cyclase-stimulating protein derived from tumors associated with humoral hypercalcemia of malignancy.J. Bone Miner. Res.2(6), 587–593 (1987).
  • Schilling T , PecherstorferM, BlindE, LeidigG, ZieglerR, RaueF. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.J. Clin. Endocrinol. Metab.76(3), 801–803 (1993).
  • Nakayama K , FukumotoS, TakedaSet al. Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia. J. Clin. Endocrinol. Metab. 81(2), 607–611 (1996).
  • Seymour JF , GagelRF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin’s disease and non-Hodgkin’s lymphomas.Blood82(5), 1383–1394 (1993).
  • Martin TJ , MoseleyJM, GillespieMT. Parathyroid hormone-related protein: biochemistry and molecular biology.Crit. Rev. Biochem. Mol. Biol.26(3–4), 377–395 (1991).
  • de Castro LF , LozanoD, Portal-NunezSet al. Comparison of the skeletal effects induced by daily administration of PTHrP (1–36) and PTHrP (107–139) to ovariectomized mice. J. Cell. Physiol. 227(4), 1752–1760 (2012).
  • Karaplis AC , LuzA, GlowackiJet al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8(3), 277–289 (1994).
  • Amizuka N , WarshawskyH, HendersonJE, GoltzmanD, KaraplisAC. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation.J. Cell Biol.126(6), 1611–1623 (1994).
  • Amizuka N , GoltzmanD, OzawaH. The biologic action of parathyroid hormone-related peptide on bone and cartilage cells.Tissue Eng.2(4), 277–287 (1996).
  • Kong XF , SchipaniE, LanskeBet al. The rat, mouse and human genes encoding the receptor for parathyroid hormone and parathyroid hormone-related peptide are highly homologous. Biochem. Biophys. Res. Commun. 200(3), 1290–1299 (1994).
  • Downey SE , HoylandJ, FreemontAJ, KnoxF, WallsJ, BundredNJ. Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue.J. Pathol.183(2), 212–217 (1997).
  • Asadi F , FarrajM, SharifiR, MalakoutiS, AntarS, KukrejaS. Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia.Hum. Pathol.27(12), 1319–1323 (1996).
  • Fuller K , OwensJM, ChambersTJ. Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells.J. Endocrinol.158(3), 341–350 (1998).
  • Datta NS , Abou-SamraAB. PTH and PTHrP signaling in osteoblasts.Cell. Signal.21(8), 1245–1254 (2009).
  • Fiaschi-Taesch NM , StewartAF. Minireview: parathyroid hormone-related protein as an intracrine factor – trafficking mechanisms and functional consequences.Endocrinology144(2), 407–411 (2003).
  • Fidler IJ . The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited.Nat. Rev. Cancer3(6), 453–458 (2003).
  • Paget S . The distribution of secondary growths in cancer of the breast. 1889.Cancer Metastasis Rev.8(2), 98–101 (1889).
  • Steeg PS . Tumor metastasis: mechanistic insights and clinical challenges.Nat. Med.12(8), 895–904 (2006).
  • Southby J , KissinMW, DanksJAet al. Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res. 50(23), 7710–7716 (1990).
  • Powell GJ , SouthbyJ, DanksJAet al. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res. 51(11), 3059–3061 (1991).
  • Malakouti S , AsadiFK, KukrejaSC, AbcarianHA, CintronJR. Parathyroid hormone-related protein expression in the human colon: immunohistochemical evaluation.Am. Surg.62(7), 540–544 (1996).
  • Shen X , RychahouPG, EversBM, FalzonM. PTHrP increases xenograft growth and promotes integrin alpha6beta4 expression and Akt activation in colon cancer.Cancer Lett.258(2), 241–252 (2007).
  • Guise TA , YinJJ, TaylorSDet al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J. Clin. Invest. 98(7), 1544–1549 (1996).
  • Iwamura M , di Sant’AgnesePA, WuGet al. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res. 53(8), 1724–1726 (1993).
  • Montgrain PR , DeftosLJ, ArenbergDet al. Prognostic implications of parathyroid hormone-related protein in males and females with non-small-cell lung cancer. Clin. Lung Cancer 12(3), 197–205 (2011).
  • Henderson MA , DanksJA, SlavinJLet al. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res. 66(4), 2250–2256 (2006).
  • Ghoussaini M , FletcherO, MichailidouKet al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat. Genet. 44(3), 312–318 (2012).
  • Dougherty KM , BlommeEA, KohAJet al. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res. 59(23), 6015–6022 (1999).
  • Coleman RE . Clinical features of metastatic bone disease and risk of skeletal morbidity.Clin. Cancer Res.12(20 Pt 2), 6243s–6249s (2006).
  • Bubendorf L , SchopferA, WagnerUet al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum. Pathol. 31(5), 578–583 (2000).
  • Chiang AC , MassagueJ. Molecular basis of metastasis.N. Engl. J. Med.359(26), 2814–2823 (2008).
  • Weilbaecher KN , GuiseTA, McCauleyLK. Cancer to bone: a fatal attraction.Nat. Rev. Cancer11(6), 411–425 (2011).
  • Loberg RD , GayedBA, OlsonKB, PientaKJ. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell–microenvironment interactions.J. Cell. Biochem.96(3), 439–446 (2005).
  • Chirgwin JM , GuiseTA. Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment.J. Cell. Biochem.102(6), 1333–1342 (2007).
  • Lam MH , BriggsLJ, HuW, MartinTJ, GillespieMT, JansDA. Importin beta recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin alpha.J. Biol. Chem.274(11), 7391–7398 (1999).
  • Lam MH , ThomasRJ, LovelandKLet al. Nuclear transport of parathyroid hormone (PTH)-related protein is dependent on microtubules. Mol. Endocrinol. 16(2), 390–401 (2002).
  • Watson PH , FraherLJ, HendyGNet al. Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues. J. Bone Miner. Res. 15(6), 1033–1044 (2000).
  • Watson PH , FraherLJ, NataleBV, KisielM, HendyGN, HodsmanAB. Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation.Bone26(3), 221–225 (2000).
  • Nardozzi JD , LottK, CingolaniG. Phosphorylation meets nuclear import: a review.Cell Commun. Signal.8, 32 (2010).
  • Nguyen MT , KaraplisAC. The nucleus: a target site for parathyroid hormone-related peptide (PTHrP) action.J. Cell. Biochem.70(2), 193–199 (1998).
  • Li J , KaraplisAC, HuangDCet al. PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target. J. Clin. Invest. 121(12), 4655–4669 (2011).
  • Gujral A , BurtonDW, TerkeltaubR, DeftosLJ. Parathyroid hormone-related protein induces interleukin 8 production by prostate cancer cells via a novel intracrine mechanism not mediated by its classical nuclear localization sequence.Cancer Res.61(5), 2282–2288 (2001).
  • Burton PB , MonizC, KnightDE. Parathyroid hormone related peptide can function as an autocrine growth factor in human renal cell carcinoma.Biochem. Biophys. Res. Commun.167(3), 1134–1138 (1990).
  • Tovar Sepulveda VA , ShenX, FalzonM. Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells.Endocrinology143(2), 596–606 (2002).
  • Massfelder T , LangH, SchordanEet al. Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene. Cancer Res. 64(1), 180–188 (2004).
  • Talon I , LindnerV, SourbierCet al. Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo. Carcinogenesis 27(1), 73–83 (2006).
  • Shen X , FalzonM. Parathyroid hormone-related protein upregulates integrin expression via an intracrine pathway in PC-3 prostate cancer cells.Regul. Pept.113(1–3), 17–29 (2003).
  • Shen X , MulaRV, EversBM, FalzonM. Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines.Regul. Pept.141(1–3), 61–72 (2007).
  • Mula RV , BhatiaV, FalzonM. PTHrP promotes colon cancer cell migration and invasion in an integrin alpha6beta4-dependent manner through activation of Rac1.Cancer Lett.298(1), 119–127 (2010).
  • Sakamoto S , KyprianouN. Targeting anoikis resistance in prostate cancer metastasis.Mol. Aspects Med.31(2), 205–214 (2010).
  • Bhatia V , MulaRV, WeigelNL, FalzonM. Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling.Mol. Cancer Res.7(7), 1119–1131 (2009).
  • Park SI , McCauleyLK. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.Endocr. Relat. Cancer19(3), 243–254 (2012).
  • Yin JJ , SelanderK, ChirgwinJMet al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103(2), 197–206 (1999).
  • Li X , LobergR, LiaoJet al. A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Res. 69(4), 1685–1692 (2009).
  • Rozel S , GalbanCJ, NicolayKet al. Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J. Cell. Biochem. 107(1), 58–64 (2009).
  • Mizutani K , SudS, McGregorNAet al. The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia 11(11), 1235–1242 (2009).
  • Loberg RD , YingC, CraigMet al. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res. 67(19), 9417–9424 (2007).
  • Horwitz MJ , TedescoMB, SereikaSMet al. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover. J. Bone Miner. Res. 26(9), 2287–2297 (2011).
  • Datta NS , ChenC, BerryJE, McCauleyLK. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.J. Bone Miner. Res.20(6), 1051–1064 (2005).
  • Datta NS , PettwayGJ, ChenC, KohAJ, McCauleyLK. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.J. Bone Miner. Res.22(7), 951–964 (2007).
  • Bonewald LF . The amazing osteocyte.J. Bone Miner. Res.26(2), 229–238 (2011).
  • Xiong J , OnalM, JilkaRL, WeinsteinRS, ManolagasSC, O’BrienCA. Matrix-embedded cells control osteoclast formation.Nat. Med.17(10), 1235–1241 (2011).
  • Nakashima T , HayashiM, FukunagaTet al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17(10), 1231–1234 (2011).
  • Powell WF Jr , BarryKJ, TulumIet al. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J. Endocrinol. 209(1), 21–32 (2011).
  • Sato K , FujiiY, KasonoKet al. Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo. Endocrinology 124(5), 2172–2178 (1989).
  • Uy HL , MundyGR, BoyceBFet al. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Cancer Res. 57(15), 3194–3199 (1997).
  • de la Mata J , UyHL, GuiseTAet al. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J. Clin. Invest. 95(6), 2846–2852 (1995).
  • Funk JL . A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases.Int. Immunopharmacol.1(6), 1101–1121 (2001).
  • Akino K , OhtsuruA, KandaKet al. Parathyroid hormone-related peptide is a potent tumor angiogenic factor. Endocrinology 141(11), 4313–4316 (2000).
  • Bakre MM , ZhuY, YinHet al. Parathyroid hormone-related peptide is a naturally occurring, protein kinase A-dependent angiogenesis inhibitor. Nat. Med. 8(9), 995–1003 (2002).
  • Liao J , LiX, KohAJet al. Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions. Int. J. Cancer 123(10), 2267–2278 (2008).
  • Zhang J , PatelL, PientaKJ. CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.Cytokine Growth Factor Rev.21(1), 41–48 (2010).
  • Roca H , VarsosZS, SudS, CraigMJ, YingC, PientaKJ. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization.J. Biol. Chem.284(49), 34342–34354 (2009).
  • Cackowski FC , AndersonJL, PatreneKDet al. Osteoclasts are important for bone angiogenesis. Blood 115(1), 140–149 (2010).
  • Guise TA , YinJJ, ThomasRJ, DallasM, CuiY, GillespieMT. Parathyroid hormone-related protein (PTHrP)-(1–139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo.Bone30(5), 670–676 (2002).
  • Onuma E , AzumaY, SaitoHMet al. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Clin. Cancer Res. 11(11), 4198–4203 (2005).
  • Furugaki K , MoriyaY, IwaiTet al. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292. Clin. Exp. Metastasis 28(7), 649–659 (2011).
  • Lorch G , GilmoreJL, KoltzPFet al. Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. Br. J. Cancer 97(2), 183–193 (2007).
  • Kaplan RN , PsailaB, LydenD. Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond.Cancer Metastasis Rev.25(4), 521–529 (2006).
  • Kaplan RN , RibaRD, ZacharoulisSet al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069), 820–827 (2005).
  • Hiratsuka S , WatanabeA, SakuraiYet al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10(11), 1349–1355 (2008).
  • Hiratsuka S , WatanabeA, AburataniH, MaruY. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis.Nat. Cell Biol.8(12), 1369–1375 (2006).
  • Kelly T , SuvaLJ, HuangYet al. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. Cancer Res. 65(13), 5778–5784 (2005).
  • Kelly T , SuvaLJ, NicksKM, MacLeodV, SandersonRD. Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis.J. Bone Miner. Res.25(6), 1295–1304 (2010).
  • Anborgh PH , MutrieJC, TuckAB, ChambersAF. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.J. Cell. Mol. Med.14(8), 2037–2044 (2010).
  • Lynch CC , HikosakaA, AcuffHBet al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7(5), 485–496 (2005).
  • Pollard JW . Tumour-educated macrophages promote tumour progression and metastasis.Nat. Rev. Cancer4(1), 71–78 (2004).
  • Younos I , DonkorM, HokeTet al. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells. Int. Immunopharmacol. 11(7), 816–826 (2011).
  • Yang L , EdwardsCM, MundyGR. Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis.J. Bone Miner. Res.25(8), 1701–1706 (2010).
  • Park SI , SadlerW, KohAJ, SokiF, McCauleyLK. Parathyroid hormone-related peptide (PTHrP) up-regulates myeloid-derived suppressor cells (MDSC) in the bone marrow, contributing to prostate cancer growth and angiogenesis. Presented at:American Society for Bone and Mineral Research 2011 Annual Meeting San Diego, CA, USA, 16–20 September 2011 (Abstract 1088).
  • Gao CL , DeanRC, PintoAet al. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction. J. Urol. 161(4), 1070–1076 (1999).
  • Langley RR , FidlerIJ. The seed and soil hypothesis revisited – the role of tumor–stroma interactions in metastasis to different organs.Int. J. Cancer128(11), 2527–2535 (2011).
  • Nguyen DX , BosPD, MassagueJ. Metastasis: from dissemination to organ-specific colonization.Nat. Rev. Cancer9(4), 274–284 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.